Annual Report 2023

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2023 99 The United Laboratories International Holdings Limited Annual Report 2023 16. EARNINGS PER SHARE The calculation of the basic earnings per share attributable to owners of the Company is based on the following data: Earnings 2023 2022 RMB’000 RMB’000 Earnings for the purposes of basic earnings per share being profit for the year attributable to owners of the Company 2,701,350 1,581,094 Number of shares 2023 2022 ‘000 ‘000 Weighted average number of ordinary shares for the purpose of basic earnings per share 1,817,027 1,819,730 As defined and disclosed in Note 33, the Group granted award shares to the Group’s directors and employees under the Share Award Scheme, the award shares are antidilutive as the Group will repurchase the shares from the open market for the award shares upon the vesting conditions underlying the respective award shares are met. No diluted earnings per share for both 2023 and 2022 were presented as there were no potential ordinary shares in issue for both 2023 and 2022.